Your browser doesn't support javascript.
Genomic Elucidation of a COVID-19 Resurgence and Local Transmission of SARS-CoV-2 in Guangzhou, China.
Jia, Hong-Ling; Li, Peng; Liu, Hong-Jie; Zhong, Jia-Yong; Qin, Peng-Zhe; Su, Wen-Zhe; Zheng, Ying-Feng; Li, Kui-Biao; Zeng, Qing; Li, Jin-Hui; Li, Li-Zhong; Cao, Lan; Wu, Ji-Bin; Chen, Yi-Yun; Jia, Lei-Li; Song, Hong-Bin; Zhang, Qi-Wei; Yang, Guang; Jing, Chun-Xia; Bo, Xiao-Chen; Zhang, Zhou-Bin; Di, Biao; Xiao, Chuan-Le; Ni, Ming.
  • Jia HL; Guangzhou Center for Disease Control and Prevention, Guangzhou, China.
  • Li P; Department of Medical Biochemistry and Molecular Biology, School of Medicine, Jinan University, Guangzhou, China.
  • Liu HJ; Chinese PLA Center for Disease Control and Prevention, Beijing, China.
  • Zhong JY; Beijing Institute of Radiation Medicine, Beijing, China.
  • Qin PZ; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
  • Su WZ; Guangzhou Center for Disease Control and Prevention, Guangzhou, China.
  • Zheng YF; Guangzhou Center for Disease Control and Prevention, Guangzhou, China.
  • Li KB; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
  • Zeng Q; Guangzhou Center for Disease Control and Prevention, Guangzhou, China.
  • Li JH; Berry Genomics Co. Ltd., Beijing, China.
  • Li LZ; Chinese PLA Center for Disease Control and Prevention, Beijing, China.
  • Cao L; Chinese PLA Center for Disease Control and Prevention, Beijing, China.
  • Wu JB; Guangzhou Center for Disease Control and Prevention, Guangzhou, China.
  • Chen YY; Guangzhou Center for Disease Control and Prevention, Guangzhou, China.
  • Jia LL; Guangzhou Center for Disease Control and Prevention, Guangzhou, China.
  • Song HB; Chinese PLA Center for Disease Control and Prevention, Beijing, China.
  • Zhang QW; Chinese PLA Center for Disease Control and Prevention, Beijing, China.
  • Yang G; Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou, China.
  • Jing CX; Department of Pathogen Biology, School of Medicine, Jinan University, Guangzhou, China.
  • Bo XC; Department of Epidemiology, School of Medicine, Jinan University, Guangzhou, China.
  • Zhang ZB; Beijing Institute of Radiation Medicine, Beijing, China.
  • Di B; Guangzhou Center for Disease Control and Prevention, Guangzhou, China.
  • Xiao CL; Guangzhou Center for Disease Control and Prevention, Guangzhou, China.
  • Ni M; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
J Clin Microbiol ; 59(8): e0007921, 2021 07 19.
Article in English | MEDLINE | ID: covidwho-1218187
ABSTRACT
While China experienced a peak and decline in coronavirus disease 2019 (COVID-19) cases at the start of 2020, regional outbreaks continuously emerged in subsequent months. Resurgences of COVID-19 have also been observed in many other countries. In Guangzhou, China, a small outbreak, involving less than 100 residents, emerged in March and April 2020, and comprehensive and near-real-time genomic surveillance of SARS-CoV-2 was conducted. When the numbers of confirmed cases among overseas travelers increased, public health measures were enhanced by shifting from self-quarantine to central quarantine and SARS-CoV-2 testing for all overseas travelers. In an analysis of 109 imported cases, we found diverse viral variants distributed in the global viral phylogeny, which were frequently shared within households but not among passengers on the same flight. In contrast to the viral diversity of imported cases, local transmission was predominately attributed to two specific variants imported from Africa, including local cases that reported no direct or indirect contact with imported cases. The introduction events of the virus were identified or deduced before the enhanced measures were taken. These results show the interventions were effective in containing the spread of SARS-CoV-2, and they rule out the possibility of cryptic transmission of viral variants from the first wave in January and February 2020. Our study provides evidence and emphasizes the importance of controls for overseas travelers in the context of the pandemic and exemplifies how viral genomic data can facilitate COVID-19 surveillance and inform public health mitigation strategies.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study Topics: Variants Limits: Humans Country/Region as subject: Africa / Asia Language: English Journal: J Clin Microbiol Year: 2021 Document Type: Article Affiliation country: JCM.00079-21

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study Topics: Variants Limits: Humans Country/Region as subject: Africa / Asia Language: English Journal: J Clin Microbiol Year: 2021 Document Type: Article Affiliation country: JCM.00079-21